Drugs / HL tablet
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02491905 | Nov 2013 → May 2015 | NAFLD1 | Huons Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HL tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02491905 ↗ |
| Route | Oral | “by oral administration” NCT02491905 ↗ |